Funder: National Institutes of Health (NIH)

Due Dates: June 5, 2022 | October 5, 2022 | February 5, 2023 | June 5, 2023 | October 5, 2023 | February 5, 2024 | June 5, 2024 | October 5, 2024 | February 5, 2025

Funding Amounts: No set budget limit; project period up to 5 years; budgets should reflect actual project needs.

Summary: Supports research using bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their products to study microbe-tumor-immune interactions and develop microbial-based cancer imaging, therapy, or diagnostics.

Key Information: Clinical trials are not allowed; applications must follow NIH SF424 (R&R) Forms Version H instructions; multidisciplinary teams encouraged; reissued as PAR-25-107 with expiration Nov 8, 2024.